Gene Query: FLOT1

Dataset Description Geneva Score
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 151.18
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 72.96
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 72.85
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 57.24
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 40.93
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 32.97
Role of CD133 molecule in WNT response and renal repair 32.64
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 32.35
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 31.68
TGF-β promotes genomic instability after loss of RUNX3 30.28
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 29.33
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 28.46
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 27.35
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 26.9
Tumor exosome integrins determine organotropic metastasis 25.76
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 25.29
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 24.81
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 24.81
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 24.38
Transcriptome analysis of SKI knock-out in HL60 cells 23.72
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 23.72
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 23.64
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 23.49
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 22.31
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 22.14
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 21.66
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 21.37
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 21.23
Gene expression changes upon drug withdrawal (Mel888 cell line) 21.16
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 21.08
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 20.66
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 20.65
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 19.65
Transcriptome analysis of U87 cells upon LINC00152 knockdown 19.51
Total RNA-seq in ALL-SIL upon JQ1 inhibition 19.37
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 19.32
RNA-sequencing of formalin fixed human primary melanoma tissue 19.25
MYCi975 regulates MYC target genes 19.23
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 18.74
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 18.74
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 18.65
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 18.51
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 18.21
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 18.2
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 18.13
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 18.13
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 18.12
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 17.97
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 17.96
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 17.79
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 17.61
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 17.6
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 17.59
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 17.45
Human neutrophil genome during PMA- and E. coli encounter-induced activation 17.45
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 17.42
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 16.94
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 16.89
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 16.89
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 16.89
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 16.69
Regulation of highly expressed hCINAP on translatome 16.45
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 16.22
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 16.22
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 16.21
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 16.19
A map of gene expression in neutrophil-like cell lines 16.17
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 16.02
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 15.94
Differentially expressed genes post knock down of lincDUSP26 15.81
ZIKV infection of monocytes activates inflammasome pathways 15.59
Genome wide expression change in LCC2 and MCF-7 cells 15.33
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 15.25
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 15.25
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 15.14
RNA expression following TMPRSS11B overexpression or depletion 15.11
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 15.1
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 15.01
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 15.01
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 14.87
TFAP2C signalling in human fibroblasts 14.84
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 14.62
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 14.52
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 14.45
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 14.43
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 14.38
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 14.36
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 14.2
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 14.04
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 14.03
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 14.03
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 13.84
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 13.84
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 13.82
Identifying the molecular mode of action of itraconazole in colorectal cancer 13.77
The comparison of high-throughput single-cell RNA-seq methods 13.74
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 13.73
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 13.58
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 13.57
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 13.56
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 13.54
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 13.52
RNA m5C Methylation in breast cancer using MeRIP-Seq 13.49
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 13.47
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 13.35
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 13.35
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 13.3
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 13.3
WRN knockout effects upon gene expression in SW48 and OVK18 13.26
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 13.01
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 13.01
Effect of disulfiram treatment on pediatric high grade glioma 12.99
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 12.97
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 12.94
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 12.94
RNA sequencing of primary human platelets and in vitro cell lines 12.94
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 12.93
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 12.91
Ectoderm specification of H1 human embryonic stem cells 12.89
12.87
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 12.78
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 12.74
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 12.71
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 12.68
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 12.66
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 12.64
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 12.59
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 12.56
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 12.47
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 12.33
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 12.33
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 12.32
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 12.31
Effect of MDK expressing Melanoma cells conditioned media in Human LEC 12.28
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 12.25
Accurate annotation of human protein-coding small open reading frames 12.21
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 12.15
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 12.15
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 12.13
TGF-β regulation of miRNA expression in pancreatic cancer 12.13
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 11.92
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 11.92
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 11.9
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 11.9
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 11.9
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 11.9
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 11.86
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 11.84
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 11.81
Gene expression profiling of KSHV-infected periodontal ligament cells 11.8
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 11.8
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 11.74
NRDE2 negatively regulates nuclear exosome functions 11.71
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 11.67
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 11.67
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 11.65
ARID1A and ARID1B loss in HCT116 cells 11.65
RNA-sequencing in irradiated and normal A549 cells. 11.63
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 11.62
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 11.55
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 11.54
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 11.49
RNA-seq of tumor cells following angiopellosis extravasation 11.48
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 11.4
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 11.4
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 11.4
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 11.29
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 11.19
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 11.16
RNA-seq differential expression studies: more sequence, or more replication? 11.14
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 11.07
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 11.07
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 11.05
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 11.03
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 11.01
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 10.99
Generation and functional characterization of MDSC-like cells 10.95
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 10.92
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 10.89
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 10.88
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 10.78
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 10.78
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 10.73
Impact of dieldrin on transcription in Jurkat T cells 10.68
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 10.65
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 10.6
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 10.55
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 10.55
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 10.51
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 10.43
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 10.41
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 10.37
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 10.37
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 10.28
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 10.24
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 10.13
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 10.1
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 10.1
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 10.09
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 10.04
RNA-seq analysis of AML cells in response to ASLAN003 10.03
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 10.02
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 10.01
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 10.0
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 10.0
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 9.96
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 9.96
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 9.95
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 9.93
RNA sequencing of human mammary epithelial cells 9.9
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 9.89
FOXD3 is a novel tumor suppressor in lung cancer 9.88
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.87
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 9.87
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 9.87
Gene expression changes associated with resistance to tagraxofusp (SL-401) 9.87
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 9.81
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 9.8
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 9.69
Integrin signaling regulates YAP/TAZ to control skin homeostasis 9.68
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 9.67
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 9.65
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 9.65
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 9.62
The regulartory role of ZCCHC24 in splicing machinery 9.59
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 9.57
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 9.57
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 9.53
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 9.49
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 9.47
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 9.42
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 9.42
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 9.41
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 9.39
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 9.36
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 9.31
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 9.3
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 9.26
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 9.25
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 9.22
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 9.22
Uridylation by TUT4 and TUT7 marks mRNA for degradation 9.21
Sensing self and nonself circular RNAs 9.19
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 9.16
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 9.16
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 9.15
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 9.15
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 9.07
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 9.07
The Genomic Landscape of Atypical Fibroxanthoma 9.06
Comprehensive comparative analysis of 5’ end RNA sequencing methods 9.06
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 8.91
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 8.88
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 8.85
Identification of global regulators of T-helper cell lineage specification 8.85
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 8.83
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 8.77
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 8.77
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells [RNA-seq] 8.66
DNA methylation state is associated with the formation of loops and links in hematopoietic stem cells 8.66
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 8.62
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 8.6
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 8.6
Regulation of Lipids is Central to Replicative Senescence 8.57
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 8.54
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 8.54
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 8.48
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 8.48
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 8.37
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 8.37
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 8.32
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 8.27
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 8.23
CD73 knockdown effect in pancreatic cancer cell lines 8.17
O-glcnAc reprograms cellular energetics 8.15
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 8.11
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 8.09
KLF6-dependent transcription in renal cancer cells 8.02
Expression and functions of long noncoding RNAs during human T helper cell differentiation 7.92
High-throughput sequencing of pluripotent cells 7.87
Fbxo32 mediated gene expression program underlies EMT and metastasis 7.85
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 7.79
CDK12 mediated transcriptional regulation in U2OS cells 7.75
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 7.71
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 7.65
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 7.61
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 7.46
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 7.46
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 7.46
Leucegene: AML sequencing (part 6) 7.43
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 7.41
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 7.41
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 7.39
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 7.35
RNAseq of T-ALL upon long non coding rna purturbation 7.34
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 7.32
mRNA expression profile of Lymphocytes by high-throuput sequencing 7.31
Macrophage Ad5f35 M2 Challenge 7.3
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 7.23
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 7.22
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 7.18
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 7.15
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 7.15
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 7.14
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 7.12
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 7.07
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 7.05
AMPK signaling for naïve pluripotency 7.04
AMPK signaling for naïve pluripotency [Hs] 7.04
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 6.97
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.94
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.94
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.93
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.93
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 6.93
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 6.93
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 6.92
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 6.88
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 6.84
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 6.8
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 6.78
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 6.77
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 6.75
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 6.73
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 6.72
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 6.72
Transcriptome of Stabilin-1 siRNA transfected human monocytes 6.68
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 6.66
Induced DNA demethylation, genome instability and transcription 6.63
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 6.63
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 6.53
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 6.5
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 6.37
HEK293 TFAM Knockout Expression Study 6.23
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 6.22
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 6.22
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 6.15
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 6.07
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 6.06
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 6.04
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 6.04
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 6.02
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 6.0
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 5.85
Endothelial gene expression analysis 5.85
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 5.84
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 5.8
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 5.8
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 5.78
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 5.74
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 5.68
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 5.68
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 5.64
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 5.54
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 5.47
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 5.42
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 5.35
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 5.34
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 5.3
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 5.25
CSL 5.17
CSL RNA-Seq on HKC and SCC cell lines 5.17
Primary Human B-cell Temporal Response to CD40L Stimulation 5.11
The cytokine environment influence on human skin-derived T cells 5.06
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 5.06
Dilated cardiomyopathy vs Myocarditis 4.97
Differential responses of human fetal brain neural stem cells to Zika virus infection 4.93
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 4.85
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.82
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 4.62
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 4.54
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 4.53
Iron response of HepG2 cells 4.52
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 4.48
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 4.45
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 4.33
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 4.33
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 4.33
The DPYSL2 gene connects mTOR and schizophrenia 4.23
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 4.15
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 4.15
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 4.01
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 3.92
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 3.92
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 3.91
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 3.86
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 3.83
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 3.83
The transcriptome and chromatin accessbility landscape of mammalian germline 3.79
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.78
ARS2 is a general suppressor of pervasive transcription [RNAseq] 3.76
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 3.72
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 3.62
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 3.6
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 3.59
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 3.56
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 3.55
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.52
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 3.38
RNA editing in nascent RNA affects pre-mRNA splicing 3.37
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 3.26
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 3.21
Human Treg NaCl stimulation 3.2
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 3.13
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 3.07
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 3.07
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 2.99
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.91
SLAM-seq for K562 endogenous mRNA decay 2.89
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 2.85
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 2.84
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 2.79
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.76
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.71
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.71
Exogenous rescue of KLHL9 in SF210 cell line 2.59
Profiling of escape kinetics of viruses subjected to RNAi 2.5
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.5
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 2.47
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 2.45
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.45
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 2.44
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 2.42
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.39
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 2.37
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.37
6mer seed toxicity in tumour suppressive microRNAs 2.3
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 2.29
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 2.28
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.25
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 2.23
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 2.22
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 2.21
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 2.21
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 2.18
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 2.18
Measure transcript integrity using RNA-seq data 2.14
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 2.08
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 2.03
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.94
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.89
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 1.86
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.85
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.83
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 1.72
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 1.72
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 1.64
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.64
Interaction between mitoNEET and NAF-1 in cancer cells 1.6
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 1.58
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 1.57
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.56
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 1.48
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 1.48
Identification of long noncoding RNAs regulated by p53 1.46
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.45
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 1.45
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 1.39
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 1.38
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 1.32
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.26
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.26
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 1.2
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 1.15
Metastasis in triple-negative breast cancer 1.15
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.1
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.1
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.09
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 0.99
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 0.99
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.99
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.99
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 0.97
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.92
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.9
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.88
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.88
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.84
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 0.83
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.8
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 0.75
Identification of a LIF-responsive replication-competent human β cell 0.75
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.72
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.71
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.62
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.39
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.39
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 0.38
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.37
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.36
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.35
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.25
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.25
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.21
Enhancer activation during EGF response 0.15
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 0.11
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.05
Transcriptomic analysis of human macrophages in 3D 0.03
The role of m6A/m-RNA methylation in stress response regulation 0.01
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation